Literature DB >> 21593164

Cryptic protein priming sites in two different domains of duck hepatitis B virus reverse transcriptase for initiating DNA synthesis in vitro.

Rajeev K Boregowda1, Li Lin, Qin Zhu, Fang Tian, Jianming Hu.   

Abstract

Initiation of reverse transcription in hepadnaviruses is accomplished by a unique protein-priming mechanism whereby a specific Y residue in the terminal protein (TP) domain of the viral reverse transcriptase (RT) acts as a primer to initiate DNA synthesis, which is carried out by the RT domain of the same protein. When separate TP and RT domains from the duck hepatitis B virus (DHBV) RT protein were tested in a trans-complementation assay in vitro, the RT domain could also serve, unexpectedly, as a protein primer for DNA synthesis, as could a TP mutant lacking the authentic primer Y (Y96) residue. Priming at these other, so-called cryptic, priming sites in both the RT and TP domains shared the same requirements as those at Y96. A mini RT protein with both the TP and RT domains linked in cis, as well as the full-length RT protein, could also initiate DNA synthesis using cryptic priming sites. The cryptic priming site(s) in TP was found to be S/T, while those in the RT domain were Y and S/T. As with the authentic TP Y96 priming site, the cryptic priming sites in the TP and RT domains could support DNA polymerization subsequent to the initial covalent linkage of the first nucleotide to the priming amino acid residue. These results provide new insights into the complex mechanisms of protein priming in hepadnaviruses, including the selection of the primer residue and the interactions between the TP and RT domains that is essential for protein priming.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593164      PMCID: PMC3147914          DOI: 10.1128/JVI.00483-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  The majority of duck hepatitis B virus reverse transcriptase in cells is nonencapsidated and is bound to a cytoplasmic structure.

Authors:  E Yao; Y Gong; N Chen; J E Tavis
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

3.  Chemical properties and separation of phosphoamino acids by thin-layer chromatography and/or electrophoresis.

Authors:  B Duclos; S Marcandier; A J Cozzone
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

4.  Mapping of the hepatitis B virus reverse transcriptase TP and RT domains by transcomplementation for nucleotide priming and by protein-protein interaction.

Authors:  R E Lanford; Y H Kim; H Lee; L Notvall; B Beames
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

5.  Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity.

Authors:  G Radziwill; W Tucker; H Schaller
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

6.  Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase.

Authors:  J Hu; C Seeger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

7.  Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA.

Authors:  G R Foster; A M Ackrill; R D Goldin; I M Kerr; H C Thomas; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

8.  Chaperones activate hepadnavirus reverse transcriptase by transiently exposing a C-proximal region in the terminal protein domain that contributes to epsilon RNA binding.

Authors:  Michael Stahl; Jürgen Beck; Michael Nassal
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

9.  Hepatitis B virus reverse transcriptase and epsilon RNA sequences required for specific interaction in vitro.

Authors:  Jianming Hu; Morgan Boyer
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

10.  Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription.

Authors:  M Weber; V Bronsema; H Bartos; A Bosserhoff; R Bartenschlager; H Schaller
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more
  14 in total

1.  In vitro epsilon RNA-dependent protein priming activity of human hepatitis B virus polymerase.

Authors:  Scott A Jones; Rajeev Boregowda; Thomas E Spratt; Jianming Hu
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

2.  Large-scale production and structural and biophysical characterizations of the human hepatitis B virus polymerase.

Authors:  Judit Vörös; Annika Urbanek; Gilles Jean Philippe Rautureau; Maggie O'Connor; Henry C Fisher; Alison E Ashcroft; Neil Ferguson
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

3.  Mapping of Functional Subdomains in the Terminal Protein Domain of Hepatitis B Virus Polymerase.

Authors:  Daniel N Clark; John M Flanagan; Jianming Hu
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

4.  Carbonyl J acid derivatives block protein priming of hepadnaviral P protein and DNA-dependent DNA synthesis activity of hepadnaviral nucleocapsids.

Authors:  Yong-Xiang Wang; Yu-Mei Wen; Michael Nassal
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

5.  A Tyr residue in the reverse transcriptase domain can mimic the protein-priming Tyr residue in the terminal protein domain of a hepadnavirus P protein.

Authors:  Jürgen Beck; Michael Nassal
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

6.  TP-RT domain interactions of duck hepatitis B virus reverse transcriptase in cis and in trans during protein-primed initiation of DNA synthesis in vitro.

Authors:  Rajeev K Boregowda; Christina Adams; Jianming Hu
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

7.  Extensive mutagenesis of the conserved box E motif in duck hepatitis B virus P protein reveals multiple functions in replication and a common structure with the primer grip in HIV-1 reverse transcriptase.

Authors:  Yong-Xiang Wang; Cheng Luo; Dan Zhao; Jürgen Beck; Michael Nassal
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

8.  Protein-primed terminal transferase activity of hepatitis B virus polymerase.

Authors:  Scott A Jones; Jianming Hu
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

Review 9.  Hepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development.

Authors:  Daniel N Clark; Jianming Hu
Journal:  Antiviral Res       Date:  2015-09-25       Impact factor: 5.970

10.  Evidence for multiple distinct interactions between hepatitis B virus P protein and its cognate RNA encapsidation signal during initiation of reverse transcription.

Authors:  Hui Feng; Ping Chen; Fei Zhao; Michael Nassal; Kanghong Hu
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.